Company intelligence / Profile preview
DP Technology
Beijing, Beijing, Chinadp.tech ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
DP Technology is pioneering the integration of artificial intelligence with scientific research to accelerate drug discovery. Its lead small molecule program DPT0218 targets Kv1.3 for immunological diseases such as IBD and atopic dermatitis; it has shown potent inhibition of T cell activation in preclinical studies. Other pipeline assets target Lp‑PLA2 for diabetic macular oedema and Alzheimer’s disease, SLC7A11 and PLK1 for neoplasms—all currently in discovery or preclinical stages[5][7].
- Therapeutic areas
- OncologyDermatologyOphthalmologyNeurology
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugate (ADC)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Viva Biotech – strategic partnership to advance RNA-targeted small-molecule drug discovery using AI4S platform[2]Lepu Biopharma – collaboration on ADC innovation leveraging computational methods[3]Mabwell – strategic cooperation to build big model platform for biopharmaceutical R&D; focus on biologics/ADC/mAb/bsAb discovery using AI models like RiDYMO®, Uni SMART, etc.[4]Consun Pharmaceutical Group – partnership focused on AI-powered drug development [9]
Beyond the preview
Go deeper on DP Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DP Technology.